The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer

Carson R., ÇELTİKÇİ B., Johnston P. G., Van Schaeybroeck S., Dunne P.

MOLECULAR CANCER THERAPEUTICS, 10 - 13 Kasım 2013, cilt.12